Schistosoma mansoni

Schistosoma mansoni is a trematode (fluke) parasite that infects humans and causes intestinal schistosomiasis, a major neglected tropical disease. It is one of the three major species of Schistosoma that commonly infect humans, the others being S. haematobium and S. japonicum.

Taxonomy

• Kingdom: Animalia
• Phylum: Platyhelminthes
• Class: Trematoda
• Subclass: Digenea
• Order: Strigeidida
• Family: Schistosomatidae
• Genus: Schistosoma
• Species: S. mansoni

Morphology Adult worms are dioecious, with separate male and female individuals. The male is approximately 10 mm long and possesses a ventral groove (gynaecophoric canal) that houses the considerably smaller, slender female (5–10 mm). Adults are covered by a tegument that mediates host immune evasion. Eggs are oval, measuring about 115–170 µm × 45–70 µm, and contain a characteristic lateral spine.

Life Cycle

1. Human host (definitive host) – Adult worms reside in the mesenteric venules of the intestine. Females deposit eggs that traverse the intestinal wall and are expelled in feces.
2. Aquatic environment – Upon reaching fresh water, miracidia (ciliated larvae) hatch from eggs within 12–24 hours.
3. Intermediate host – Miracidia infest specific freshwater snails of the genus Biomphalaria (e.g., B. glabrata, B. pfeifferi). Inside the snail, they develop into sporocysts, producing thousands of cercariae.
4. Infective stage – Free‑swimming cercariae are released from snails and penetrate human skin during contact with contaminated water. They lose their tails, become schistosomula, and migrate via the bloodstream to the lungs and then to the hepatic portal system, where they mature into adult worms.

Epidemiology S. mansoni is endemic in sub‑Saharan Africa, the Middle East, the Caribbean, and parts of South America. Endemic transmission is associated with freshwater bodies used for agriculture, domestic activities, and recreation. Prevalence is highest among school‑aged children and occupational groups with frequent water contact. The World Health Organization estimates that over 70 million people are infected globally, with additional millions at risk.

Pathogenesis Clinical disease results primarily from the host immune response to lodged eggs. Granuloma formation in intestinal and hepatic tissue leads to mucosal ulceration, fibrosis, portal hypertension, and, in chronic cases, hepatosplenomegaly. Acute infection (cercarial dermatitis or “swimmer’s itch”) may be followed by Katayama fever, characterized by fever, eosinophilia, and constitutional symptoms.

Diagnosis

• Parasitological: Microscopic identification of characteristic eggs in stool specimens (Kato‑Katz thick smear) is the standard method.
• Serological: Detection of antibodies (ELISA, immunoblot) can indicate exposure but does not differentiate active from past infection.
• Antigen detection: Circulating cathodic antigen (CCA) and circulating anodic antigen (CAA) assays provide improved sensitivity, especially in low‑intensity infections.
• Imaging: Ultrasound may reveal periportal fibrosis or hepatomegaly in chronic disease.

Treatment The drug of choice is praziquantel, administered orally at a single dose of 40 mg/kg body weight (often split into two doses on the same day). Praziquantel is highly effective against adult worms, with cure rates exceeding 85 % in most settings. Reinfection is common in endemic areas; thus, repeated treatment (mass drug administration) is recommended for at‑risk populations.

Control and Prevention

• Mass drug administration (MDA): Periodic community‑wide praziquantel distribution, especially targeting school‑aged children.
• Snail control: Environmental management (e.g., habitat modification, mollusciciding) to reduce Biomphalaria populations.
• Health education: Promoting safe water contact practices, use of protective footwear, and sanitation improvements to limit fecal contamination of water bodies.
• Water, sanitation, and hygiene (WASH) initiatives: Provision of safe drinking water and latrines to interrupt transmission cycles.

Research Highlights

• Genomic sequencing of S. mansoni has identified gene families involved in immune evasion, tegument remodeling, and drug resistance, informing vaccine and therapeutic research.
• Ongoing trials assess vaccine candidates targeting tegument proteins (e.g., Sm-TSP‑2) and recombinant antigens.
• Studies on praziquantel resistance mechanisms are limited but monitor for potential emergence in regions with intensive MDA.

Public Health Impact Schistosomiasis caused by S. mansoni contributes to anemia, stunted growth, reduced school performance, and economic loss in endemic communities. Integrated control programs that combine chemotherapy, snail management, and WASH strategies are essential for disease reduction and eventual elimination.